Ethos Technologies Inc. - Class A (LIFE) analyst actions
Rating and price-target actions on LIFE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LIFE overview →
No LIFE analyst action events in the measured window.
Nothing matched in the current window — the LIFE overview has every event we measure for this name.
Get an email when LIFE moves on news →Keep exploring
More LIFE: earnings → · SEC filings → · LIFE overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
| COLOPLAST AS SP/ADR (CLPBY) | 82 | +0.13% | 59% |
| BASILEA PHARM AG AKT SHS (BPMUF) | 81 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.